South Australian immunoGENomics Cancer Institute
@saigenci.bsky.social
SAiGENCI is South Australia's world-class cancer research institute, jointly resourced by the Commonwealth Department of Health and Aged Care, Central Adelaide Local Health Network (CALHN) and the University of Adelaide.
Congratulations to @saigenci.bsky.social's @aachinger.bsky.social awarded 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. Dr Achinger-Kawecka leads our 3D Chromatin Organisation Laboratory and receives $1.375m over 5 years to support her work. Read more at bit.ly/3Wva9HH
October 31, 2025 at 2:10 AM
Congratulations to @saigenci.bsky.social's @aachinger.bsky.social awarded 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. Dr Achinger-Kawecka leads our 3D Chromatin Organisation Laboratory and receives $1.375m over 5 years to support her work. Read more at bit.ly/3Wva9HH
📣 @saigenci.bsky.social congratulate Professor Jose Polo on his election as Fellow of the Australian Academy of Health & Medical Sciences (AAHMS). Jose is Program Lead for Cancer Epigenetics @SAiGENCI and Director @acepigenetics.bsky.social. Many congratulations Jose! aahms.org/news/29-of-a...
29 of Australia’s leading health and medical researchers elected as AAHMS Fellows - AAHMS
The Australian Academy of Health and Medical Sciences (AAHMS) has announced the election of 29 new Fellows for 2025, recognising the nation’s most outstandi ...
aahms.org
October 29, 2025 at 4:43 AM
📣 @saigenci.bsky.social congratulate Professor Jose Polo on his election as Fellow of the Australian Academy of Health & Medical Sciences (AAHMS). Jose is Program Lead for Cancer Epigenetics @SAiGENCI and Director @acepigenetics.bsky.social. Many congratulations Jose! aahms.org/news/29-of-a...
Reposted by South Australian immunoGENomics Cancer Institute
Luke is a group leader at @saigenci.bsky.social & @acepigenetics.bsky.social, within the University of Adelaide. He has extensive expertise in epigenetic regulation and a strong commitment to fostering creative, inclusive science. A perspective we can’t wait to share with our community!
October 9, 2025 at 10:25 PM
Luke is a group leader at @saigenci.bsky.social & @acepigenetics.bsky.social, within the University of Adelaide. He has extensive expertise in epigenetic regulation and a strong commitment to fostering creative, inclusive science. A perspective we can’t wait to share with our community!
Reposted by South Australian immunoGENomics Cancer Institute
🧵 1/
💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗
We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer.
#BreastCancerAwarenessMonth #AEpiA
💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗
We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer.
#BreastCancerAwarenessMonth #AEpiA
October 17, 2025 at 12:53 AM
🧵 1/
💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗
We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer.
#BreastCancerAwarenessMonth #AEpiA
💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗
We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer.
#BreastCancerAwarenessMonth #AEpiA
📣Congratulations to Professor Brendan Jenkins, @saigenci.bsky.social's Program Lead for Tumour Inflammation and Immunotherapy, on being awarded the Japanese Cancer Association (JCA) International Award. The first Australian recipient! @jenkins-lab.bsky.social 👏
Very honoured to be the first Australian recipient of the prestigious Japanese Cancer Association (JCA) International Award, presented at the annual JCA2025 conference in Kanazawa. Special thanks to my JCA colleagues, especially JCA President, Prof Masanobu Oshima.
@saigenci.bsky.social
@saigenci.bsky.social
October 3, 2025 at 1:16 AM
📣Congratulations to Professor Brendan Jenkins, @saigenci.bsky.social's Program Lead for Tumour Inflammation and Immunotherapy, on being awarded the Japanese Cancer Association (JCA) International Award. The first Australian recipient! @jenkins-lab.bsky.social 👏
Reposted by South Australian immunoGENomics Cancer Institute
Thank you to the China International Talent Exchange Foundation for hosting our young ACE researchers! We shared our epigenetic research and cutting-edge technologies, whilst learning all about the pioneering research in Harbin, China. A wonderful exchange for ideas!🧪 @saigenci.bsky.social
September 16, 2025 at 5:23 AM
Thank you to the China International Talent Exchange Foundation for hosting our young ACE researchers! We shared our epigenetic research and cutting-edge technologies, whilst learning all about the pioneering research in Harbin, China. A wonderful exchange for ideas!🧪 @saigenci.bsky.social
📣Last night 90+ uni students attended the inaugural "Evening with Cancer Researchers". Hosted by @saigenci.bsky.social with representatives from University of Adelaide, UniSA's CCB and @sahmri.bsky.social. Great to see the enthusiasm of our next gen cancer researchers! @josundstrom.bsky.social 🔬
September 3, 2025 at 5:32 AM
📣Last night 90+ uni students attended the inaugural "Evening with Cancer Researchers". Hosted by @saigenci.bsky.social with representatives from University of Adelaide, UniSA's CCB and @sahmri.bsky.social. Great to see the enthusiasm of our next gen cancer researchers! @josundstrom.bsky.social 🔬
Reposted by South Australian immunoGENomics Cancer Institute
Welcome new @saigenci.bsky.social PhD students! SAiGENCI student reps Percy Zhang (Polo lab @acepigenetics.bsky.social ) and An Nguen were thrilled to welcome everyone with this warm gathering!
August 21, 2025 at 2:56 PM
Welcome new @saigenci.bsky.social PhD students! SAiGENCI student reps Percy Zhang (Polo lab @acepigenetics.bsky.social ) and An Nguen were thrilled to welcome everyone with this warm gathering!
Reposted by South Australian immunoGENomics Cancer Institute
Next in our #AI webinars:
Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns
Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs
More info www.biocommons.org.au/events/ai-se...
Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns
Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs
More info www.biocommons.org.au/events/ai-se...
August 12, 2025 at 4:52 AM
Next in our #AI webinars:
Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns
Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs
More info www.biocommons.org.au/events/ai-se...
Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns
Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs
More info www.biocommons.org.au/events/ai-se...
Reposted by South Australian immunoGENomics Cancer Institute
🧬 DNA’s message is only part of the story.
Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.
🔗 More in our Impact Report: bit.ly/3EVhwD8
#DecodingTheUniverse #ScienceWeek
Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.
🔗 More in our Impact Report: bit.ly/3EVhwD8
#DecodingTheUniverse #ScienceWeek
August 12, 2025 at 12:57 AM
🧬 DNA’s message is only part of the story.
Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.
🔗 More in our Impact Report: bit.ly/3EVhwD8
#DecodingTheUniverse #ScienceWeek
Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.
🔗 More in our Impact Report: bit.ly/3EVhwD8
#DecodingTheUniverse #ScienceWeek
@saigenci.bsky.social are hiring! Work with our fabulous Group Leader, Dr Luke Isbel and the Molecular Epigenetics Laboratory. Luke is seeking a highly motivated, creative researcher to join his team. See all the details at careers.adelaide.edu.au/cw/en/job/51... @acepigenetics.bsky.social
Learn more about South Australia's new university for the future.
careers.adelaide.edu.au
August 13, 2025 at 1:07 AM
@saigenci.bsky.social are hiring! Work with our fabulous Group Leader, Dr Luke Isbel and the Molecular Epigenetics Laboratory. Luke is seeking a highly motivated, creative researcher to join his team. See all the details at careers.adelaide.edu.au/cw/en/job/51... @acepigenetics.bsky.social
📣On Friday, @saigenci.bsky.social hosted a delegation from the Chinese biomedical industry as part of the SJTU-AU Innovation Connect 2025 Australia Biomedical Inspection. Thanks to Lan Nguyen, Michael Roy, Fuji Li and Jing Xu representing @saigenci.bsky.social 👏
August 11, 2025 at 3:02 AM
📣On Friday, @saigenci.bsky.social hosted a delegation from the Chinese biomedical industry as part of the SJTU-AU Innovation Connect 2025 Australia Biomedical Inspection. Thanks to Lan Nguyen, Michael Roy, Fuji Li and Jing Xu representing @saigenci.bsky.social 👏
Reposted by South Australian immunoGENomics Cancer Institute
Join #AI and #Immunology!
📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.
CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...
#PhDOpportunity #MachineLearning #SingleCell
📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.
CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...
#PhDOpportunity #MachineLearning #SingleCell
August 6, 2025 at 2:56 AM
Join #AI and #Immunology!
📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.
CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...
#PhDOpportunity #MachineLearning #SingleCell
📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.
CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...
#PhDOpportunity #MachineLearning #SingleCell
Reposted by South Australian immunoGENomics Cancer Institute
Huge congrats to the ACE team led by Prof Polo, Dr Sullivan, Dr Bhattacharjee, as well as Prof Lister & Dr Pope on their MRFF Grant, tackling the challenge of helping patients with rare neural diseases! @saigenci.bsky.social @ryanlister.bsky.social @perkinsinstitute.bsky.social tinyurl.com/5t4e9x6n
Stem cell funding to benefit epigenetic study
tinyurl.com
July 28, 2025 at 1:04 PM
Huge congrats to the ACE team led by Prof Polo, Dr Sullivan, Dr Bhattacharjee, as well as Prof Lister & Dr Pope on their MRFF Grant, tackling the challenge of helping patients with rare neural diseases! @saigenci.bsky.social @ryanlister.bsky.social @perkinsinstitute.bsky.social tinyurl.com/5t4e9x6n
@saigenci.bsky.social are excited to welcome two new researchers through a fellowship program funded by the Ainsworth Foundation. Dr Georgette Radford and Dr Tamsin Lannagan join the Tumour Inflammation and Immunotherapy program. Read more at www.adelaide.edu.au/newsroom/new... 🔬🧪👏
Fellows advance immunotherapy and tumour inflammation research
www.adelaide.edu.au
July 29, 2025 at 2:56 AM
@saigenci.bsky.social are excited to welcome two new researchers through a fellowship program funded by the Ainsworth Foundation. Dr Georgette Radford and Dr Tamsin Lannagan join the Tumour Inflammation and Immunotherapy program. Read more at www.adelaide.edu.au/newsroom/new... 🔬🧪👏
Great work Team @saigenci.bsky.social raising over $900 for cancer research at today's The Longest Table morning tea. Donations are still rolling in at www.thelongesttable.com.au/fundraisers/... Supporting THRFG. Together let's #forkcancer! 👊
July 28, 2025 at 5:24 AM
Great work Team @saigenci.bsky.social raising over $900 for cancer research at today's The Longest Table morning tea. Donations are still rolling in at www.thelongesttable.com.au/fundraisers/... Supporting THRFG. Together let's #forkcancer! 👊
📣 @saigenci.bsky.social thrilled to congratulate Professor Lan Nguyen awarded funding through the ARC's 2025 Future Fellowships scheme for his project "Deciphering contextual multi-pathway crosstalk in cellular decision making". @saigenci.bsky.social's first Future Fellow! bit.ly/4lobxqv 💻🔬👏
www.arc.gov.au
July 10, 2025 at 4:20 AM
📣 @saigenci.bsky.social thrilled to congratulate Professor Lan Nguyen awarded funding through the ARC's 2025 Future Fellowships scheme for his project "Deciphering contextual multi-pathway crosstalk in cellular decision making". @saigenci.bsky.social's first Future Fellow! bit.ly/4lobxqv 💻🔬👏
👏Congratulations to Dr Mohamed Saad on your @curecancer.bsky.social Researcher of the Year 2025 award. Proud to have you continuing your important work @saigenci.bsky.social! 🧪🔬👊 www.curecancer.com.au/blog/celebra...
Celebrating brilliance and generosity: Our Cure Cancer 2025 Researcher of the Year Reception
www.curecancer.com.au
June 19, 2025 at 1:41 AM
👏Congratulations to Dr Mohamed Saad on your @curecancer.bsky.social Researcher of the Year 2025 award. Proud to have you continuing your important work @saigenci.bsky.social! 🧪🔬👊 www.curecancer.com.au/blog/celebra...
Reposted by South Australian immunoGENomics Cancer Institute
📅 SAVE THE DATE - Our much-loved #PhD Course is turning 10!
🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.
👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.
👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
May 1, 2025 at 4:20 AM
📅 SAVE THE DATE - Our much-loved #PhD Course is turning 10!
🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.
👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.
👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
Updated results from Australian-led ENZAMET trial highlighting long-term outcomes with XTANDI® in mHSPC to be presented at #ASCO25. @saigenci.bsky.social Director @chrissweens1.bsky.social key leader in the ENZAMET study. Check out the full story at oncologynews.com.au/latest-news/...
ASCO 2025: ARCHES and Australian-led ENZAMET prostate cancer trials to present XTANDI® (enzalutamide) data
oncologynews.com.au
June 2, 2025 at 4:54 AM
Updated results from Australian-led ENZAMET trial highlighting long-term outcomes with XTANDI® in mHSPC to be presented at #ASCO25. @saigenci.bsky.social Director @chrissweens1.bsky.social key leader in the ENZAMET study. Check out the full story at oncologynews.com.au/latest-news/...
📣 @saigenci.bsky.social are now on @bsky.app! Follow us for the latest news on our exciting research!
May 23, 2025 at 5:37 AM
📣 @saigenci.bsky.social are now on @bsky.app! Follow us for the latest news on our exciting research!